Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05012150 · ClinicalTrials.gov registry record

A Pilot Study in Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis

A clinical trial of Chronic Pancreatitis, sponsored by Ohio State University.

Active
Registry status
32
Enrollment target
1
Study location

NCT05012150: Active study of Chronic Pancreatitis, sponsored by Ohio State University.

NCT05012150 is a study of Chronic Pancreatitis that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 32 participants, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05012150, a study of Chronic Pancreatitis, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
32 participants
Enrollment target
1
Study location

Study Summary

This study is a prospective study designed to assess the effect of pancreatic endotherapy on quality of life, pain levels, pancreatic exocrine function, and endocrine function.

Primary Outcome

Quality of life will be primarily assessed using the PANcreatitis Quality of Life Instrument (PANQOLI). Quality of life will be assessed before and after endotherapy (1, 3, 6, and 12 months). This instrument is based on a 0-87 scale with higher scores representing improved quality of life.

Conditions Studied

Study Locations (1)

Ohio

  • The Ohio State University Wexner Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2021-01-05
Est. Completion 2026-12-30
Ohio State University

552 total trials

What the registry record for NCT05012150 still lists

NCT05012150 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 688-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 0 interventions.

NCT05012150 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05012150 about?

NCT05012150 is a clinical study titled "A Pilot Study in Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis". This study is a prospective study designed to assess the effect of pancreatic endotherapy on quality of life, pain levels, pancreatic exocrine function, and endocrine function.

What is the current status of trial NCT05012150?

This trial is currently active not recruiting. The enrollment target is 32 participants. The study started on 2021-01-05. Estimated completion is 2026-12-30.

What conditions does trial NCT05012150 study?

This clinical trial studies the following conditions: Chronic Pancreatitis.

Who is sponsoring clinical trial NCT05012150?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05012150 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05012150's enrollment target sits among peer trials

32 31st of 42 higher than 12 of 42 other Chronic Pancreatitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05012150, the US trial registry maintained by the National Library of Medicine. NCT05012150 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.